Business Description
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 61.78 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -15.5 | |||||
3-Year EPS without NRI Growth Rate | -13.6 | |||||
3-Year FCF Growth Rate | -13.7 | |||||
3-Year Book Growth Rate | -19 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.56 | |||||
9-Day RSI | 25.92 | |||||
14-Day RSI | 16.73 | |||||
6-1 Month Momentum % | -92.92 | |||||
12-1 Month Momentum % | -94.19 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.58 | |||||
Quick Ratio | 6.58 | |||||
Cash Ratio | 6.27 | |||||
Days Payable | 960.77 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.4 | |||||
Shareholder Yield % | -0.15 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -53.15 | |||||
ROA % | -45 | |||||
ROIC % | -207.79 | |||||
ROC (Joel Greenblatt) % | -4122.37 | |||||
ROCE % | -50.17 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.19 | |||||
Price-to-Tangible-Book | 1.66 | |||||
EV-to-EBIT | -0.53 | |||||
EV-to-EBITDA | -0.54 | |||||
EV-to-Forward-EBITDA | -0.4 | |||||
EV-to-FCF | -0.46 | |||||
Price-to-Net-Current-Asset-Value | 1.69 | |||||
Price-to-Net-Cash | 1.8 | |||||
Earnings Yield (Greenblatt) % | -188.68 | |||||
FCF Yield % | -64.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Ultimovacs ASA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | |||
EPS (TTM) (kr) | -5.2 | ||
Beta | 0.28 | ||
Volatility % | 109.77 | ||
14-Day RSI | 16.73 | ||
14-Day ATR (kr) | 0.180937 | ||
20-Day SMA (kr) | 7.048 | ||
12-1 Month Momentum % | -94.19 | ||
52-Week Range (kr) | 6.74 - 160.8 | ||
Shares Outstanding (Mil) | 34.41 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ultimovacs ASA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ultimovacs ASA Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Ultimovacs ASA Frequently Asked Questions
What is Ultimovacs ASA(OSTO:ULTIo)'s stock price today?
When is next earnings date of Ultimovacs ASA(OSTO:ULTIo)?
Does Ultimovacs ASA(OSTO:ULTIo) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |